Recursion REC-4881 Phase 2 Results: What the FAP Data, Cash Runway and Partner Milestones Mean for the AI Biotech
The Recursion REC-4881 Phase 2 results meet a $748.7 million pro forma cash pile and new partner milestones. A business read of the AI biotech story.